Intravenous Solutions Market Forecasts to 2030 – Global Analysis By Type (Total Parenteral Nutrition and Partial Parenteral Nutrition), Composition (Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acids and Other Composi

Intravenous Solutions Market Forecasts to 2030 – Global Analysis By Type (Total Parenteral Nutrition and Partial Parenteral Nutrition), Composition (Carbohydrates, Vitamins and Minerals, Parenteral Lipid Emulsion, Single Dose Amino Acids and Other Compositions), Solution Type, Bag Type, Application, End User and By Geography


According to Stratistics MRC, the Global Intravenous Solutions Market is accounted for $13.09 billion in 2023 and is expected to reach $25.5 billion by 2030 growing at a CAGR of 10.0 % during the forecast period. Intravenous solutions, also called IV solutions, are sterile liquid treatments that are injected into a patient's veins by means of an intravenous line. These treatments are used for a variety of essential medical functions, such as rehydration, medicine delivery, and nutritional support, IV solutions are used to restore and maintain a patient's fluid and electrolyte balance, particularly when oral intake is insufficient or rapid absorption is required. They are composed of a precisely balanced blend of water, nutrients, and sometimes drugs and are a crucial part of contemporary healthcare, guaranteeing efficient treatment and patient support in a range of clinical settings, from hospitals to outpatient care, by supplying necessary fluids and medicinal chemicals straight into the bloodstream.

According to the guidelines by American Society for Parenteral and Enteral Nutrition (ASPEN), in 2020, the early parenteral nutrition should be initiated as soon as possible in the high-risk patient for whom early gastric enteral nutrition is not feasible.

Market Dynamics

Driver

New developments in IV solutions

As the developments involve the creation of specialized formulations with improved stability, solubility, and bioavailability. Additionally, modern ingredient technology makes it possible to create intravenous solutions that can transport a wider variety of therapeutic agents, such as complicated drugs and nutrients. As a result of these developments, it is now possible to treat a wider range of medical diseases by improving treatment efficacy and broadening the market's capacities. Therefore, the market for intravenous solutions benefits from being able to provide more sophisticated and specialized solutions, which enhance patient care and treatment outcomes and thus significantly drives the market growth.

Restraint

High cost

IV solutions can be pricey, especially when made with complicated ingredients or in specialist formulations. Moreover, the price of manufacturing, packaging, and quality control can affect the overall cost of IV solutions. Hence, this pricing aspect may restrict market access, particularly in areas with limited resources or poor healthcare infrastructure.

Opportunity

Increase in awareness

Preventive and holistic healthcare methods are in greater demand as people grow more health-conscious. Intravenous solutions are in demand not just for medical treatment but also for wellness and vitality reasons. They are frequently used for rehydration, immunological support, and nutrient supplementation. Furthermore, customized IV therapy is becoming more and more popular as a way to reduce deficiencies, increase energy, and improve general wellbeing. Moreover, clinics and providers offer intravenous solutions that meet the wellness and performance objectives of a health-conscious generation, which thus propel the market size.

Threat

Lack of standardization and quality

The consistency of product performance and quality, which is essential for patient safety, might be hampered by varying quality and safety standards. Moreover, the absence of unified regulations across regions can lead to disparities in manufacturing practices and product labeling, making it challenging for healthcare providers to ensure the reliability of intravenous solutions. Therefore, this lack of standardization and regulatory oversight can result in increased risks and complexities in the market, emphasizing the need for comprehensive, globally recognized guidelines to ensure the safety and efficacy of these critical medical products.

Covid-19 Impact

The market for intravenous solutions was significantly negatively impacted by the COVID-19 epidemic. Healthcare facilities experienced rare resource pressures and were frequently overburdened, which resulted in shortages and logistical difficulties when locating and dispensing these vital medical fluids. Additionally, investments in the healthcare industry were impeded by the economic collapse and uncertainties. Therefore, despite rising demand, the pandemic posed logistical and financial challenges for the market for intravenous solutions, adversely impacting both accessibility and supply.

The Dextran segment is expected to be the largest during the forecast period

The Dextran segment is estimated to hold the largest share, as these treatments are used in healthcare facilities to boost blood flow and lower the chance of clot formation, primarily during operations and other medical procedures. Additionally, these IV solutions based on dextran, function as plasma expanders, enhancing circulation and assisting in blood pressure maintenance. They are crucial in circumstances where patients can experience bleeding or need hemodynamic support. Thus, intravenous solutions based on dextran are an essential part of the larger intravenous solutions market in the healthcare sector since they are essential in sustaining patient wellbeing during medical operations.

The large volume bags segment is expected to have the highest CAGR during the forecast period

The large volume bags segment is anticipated to have highest CAGR during the forecast period, due to a variety of uses in healthcare, such as nutrient delivery, medicine administration, and hydration, these bags are essential. Moreover, in hospitals, clinics, and other medical facilities, large-volume bags are frequently utilized to deliver effective and controlled intravenous therapy to patients. Hence, they are a backbone of the intravenous solutions market in the healthcare industry because they are flexible in accepting different types of solutions and are especially important for patients needing prolonged treatments.

Region with largest share

Europe commanded the largest market share during the extrapolated period owing to the healthcare system's enormous patient population, the prominence of important players, the accessibility of drugs, the sophistication of the healthcare systems, and the advantageous reimbursement practices. Furthermore, the market for intravenous (IV) solutions in Europe will probably develop as a result of government support for the National Health Service and health insurance as well as industry technological advancements. Additionally, the intravenous solution market in the United Kingdom had the highest market share, while the intravenous solution market in France had the quickest rate of expansion in the continent of Europe.

Region with highest CAGR

Asia Pacific is expected to witness highest CAGR over the projection period, owing to rapid growth, which can be attributed to the high investment made in research by both public and private entities, as well as technological developments and an increase in the number of cooperative relationships between different stakeholders, including the healthcare industry, universities, and others. Therefore, the rising prevalence of chronic diseases brought on by unhealthy food consumption patterns and the growing choice for cost-effective care are two significant factors that are projected to propel market growth in the Asia Pacific region.

Key players in the market

Some of the key players in the Intravenous Solutions Market include ICU Medical, Inc., B. Braun Melsungen Ag, JW Life Science, Baxter International Inc., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, Amanta Healthcare, Grifols, S.A, Salius Pharma Private Limited., Pfizer, Inc., Axa Parenterals Ltd, Ajinomoto Co., Inc., Otsuka Pharmaceutical Co., Ltd, Sichuan Kelun Pharmaceutical Co Ltd, Soxa Formulations & Research Pvt. Ltd and Braun Melsungen AG.

Key Developments

In March 2022, Otsuka Pharmaceutical received regulatory approval in Japan for the sale of SAMTASU intravenous infusion for treating cardiac edema.

In February 2022, B. Braun Medical received the US FDA approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.

In September 2021, B. Braun Medical Inc. launched CARESAFE IV Administration Sets with an Optional AirStop component.

In July 2021, Grifols S.A. announced the establishment of an intravenous (IV) solutions production plant in Nigeria.

Types Covered
• Total Parenteral Nutrition
• Partial Parenteral Nutrition

Compositions Covered
• Carbohydrates
• Vitamins and Minerals
• Parenteral Lipid Emulsion
• Single Dose Amino Acids
• Other Compositions

Solution Types Covered
• Dextran
• Saline
• Hypertonic Saline
• Amino Acid
• Normal Saline
• Lactated Ringer’s
• Heparin And Trace Elements
• Vitamins & Minerals
• Mixed Solutions

Bag Types Covered
• Large Volume Bags
• Small Volume Bags

Applications Covered
• Nutritional IV Solution
• Blood IV Solution
• Basic IV Solution
• Irrigation IV Solution
• Drug IV Solution

End Users Covered
• Clinics
• Hospital
• Ambulatory Surgery Centers
• Home Care Settings

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact Of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Intravenous Solutions Market, By Type
5.1 Introduction
5.2 Total Parenteral Nutrition
5.3 Partial Parenteral Nutrition
6 Global Intravenous Solutions Market, By Composition
6.1 Introduction
6.2 Carbohydrates
6.3 Vitamins And Minerals
6.4 Parenteral Lipid Emulsion
6.5 Single Dose Amino Acids
6.6 Other Compositions
7 Global Intravenous Solutions Market, By Solution Type
7.1 Introduction
7.2 Dextran
7.3 Saline
7.4 Hypertonic Saline
7.5 Amino Acid
7.6 Normal Saline
7.7 Lactated Ringer’s
7.8 Heparin And Trace Elements
7.9 Vitamins & Minerals
7.1 Mixed Solutions
8 Global Intravenous Solutions Market, By Bag Type
8.1 Introduction
8.2 Large Volume Bags
8.3 Small Volume Bags
9 Global Intravenous Solutions Market, By Application
9.1 Introduction
9.2 Nutritional IV Solution
9.3 Blood IV Solution
9.4 Basic IV Solution
9.5 Irrigation IV Solution
9.6 Drug IV Solution
10 Global Intravenous Solutions Market, By End User
10.1 Introduction
10.2 Clinics
10.3 Hospital
10.4 Ambulatory Surgery Centers
10.5 Home Care Settings
11 Global Intravenous Solutions Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 ICU Medical, Inc.
13.2 B. Braun Melsungen Ag
13.3 JW Life Science
13.4 Baxter International Inc.
13.5 Fresenius Kabi USA, LLC
13.6 Vifor Pharma Management Ltd
13.7 Amanta Healthcare
13.8 Grifols, S.A
13.9 Salius Pharma Private Limited.
13.10 Pfizer, Inc.
13.11 Axa Parenterals Ltd
13.12 Ajinomoto Co., Inc.
13.13 Otsuka Pharmaceutical Co., Ltd
13.14 Sichuan Kelun Pharmaceutical Co Ltd
13.15 Soxa Formulations & Research Pvt. Ltd
13.16 Braun Melsungen AG
List of Tables
Table 1 Global Intravenous Solutions Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Intravenous Solutions Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Intravenous Solutions Market Outlook, By Total Parenteral Nutrition (2021-2030) ($MN)
Table 4 Global Intravenous Solutions Market Outlook, By Partial Parenteral Nutrition (2021-2030) ($MN)
Table 5 Global Intravenous Solutions Market Outlook, By Composition (2021-2030) ($MN)
Table 6 Global Intravenous Solutions Market Outlook, By Carbohydrates (2021-2030) ($MN)
Table 7 Global Intravenous Solutions Market Outlook, By Vitamins And Minerals (2021-2030) ($MN)
Table 8 Global Intravenous Solutions Market Outlook, By Parenteral Lipid Emulsion (2021-2030) ($MN)
Table 9 Global Intravenous Solutions Market Outlook, By Single Dose Amino Acids (2021-2030) ($MN)
Table 10 Global Intravenous Solutions Market Outlook, By Other Compositions (2021-2030) ($MN)
Table 11 Global Intravenous Solutions Market Outlook, By Solution Type (2021-2030) ($MN)
Table 12 Global Intravenous Solutions Market Outlook, By Dextran (2021-2030) ($MN)
Table 13 Global Intravenous Solutions Market Outlook, By Saline (2021-2030) ($MN)
Table 14 Global Intravenous Solutions Market Outlook, By Hypertonic Saline (2021-2030) ($MN)
Table 15 Global Intravenous Solutions Market Outlook, By Amino Acid (2021-2030) ($MN)
Table 16 Global Intravenous Solutions Market Outlook, By Normal Saline (2021-2030) ($MN)
Table 17 Global Intravenous Solutions Market Outlook, By Lactated Ringer’s (2021-2030) ($MN)
Table 18 Global Intravenous Solutions Market Outlook, By Heparin And Trace Elements (2021-2030) ($MN)
Table 19 Global Intravenous Solutions Market Outlook, By Vitamins & Minerals (2021-2030) ($MN)
Table 20 Global Intravenous Solutions Market Outlook, By Mixed Solutions (2021-2030) ($MN)
Table 21 Global Intravenous Solutions Market Outlook, By Bag Type (2021-2030) ($MN)
Table 22 Global Intravenous Solutions Market Outlook, By Large Volume Bags (2021-2030) ($MN)
Table 23 Global Intravenous Solutions Market Outlook, By Small Volume Bags (2021-2030) ($MN)
Table 24 Global Intravenous Solutions Market Outlook, By Application (2021-2030) ($MN)
Table 25 Global Intravenous Solutions Market Outlook, By Nutritional IV Solution (2021-2030) ($MN)
Table 26 Global Intravenous Solutions Market Outlook, By Blood IV Solution (2021-2030) ($MN)
Table 27 Global Intravenous Solutions Market Outlook, By Basic IV Solution (2021-2030) ($MN)
Table 28 Global Intravenous Solutions Market Outlook, By Irrigation IV Solution (2021-2030) ($MN)
Table 29 Global Intravenous Solutions Market Outlook, By Drug IV Solution (2021-2030) ($MN)
Table 30 Global Intravenous Solutions Market Outlook, By End User (2021-2030) ($MN)
Table 31 Global Intravenous Solutions Market Outlook, By Clinics (2021-2030) ($MN)
Table 32 Global Intravenous Solutions Market Outlook, By Hospital (2021-2030) ($MN)
Table 33 Global Intravenous Solutions Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
Table 34 Global Intravenous Solutions Market Outlook, By Home Care Settings (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings